This MAb recognizes TGF beta 1, 2 and 3. Three TGFĪ �s have been identified in mammals. TGFĪ �1, TGFĪ �2 and TGFĪ �3 are each synthesized as precursor proteins that are very similar in that each is cleaved to yield a 112 amino acid polypeptide that remains associated with the latent portion of the molecules. Biologically active TGFĪ � requires dimerization of the monomers (usually homodimers) and release of the latent peptide portion. Overall, the mature region of the TGFĪ �3 protein has approximately 80% identity to the mature region of both TGFĪ �1 and TGFĪ �2. However, the NH2 terminals or precursor regions of their molecules share only 27% sequence identity. TGFĪ �ā€™s inhibit the growth of epithelial cells and stimulate the growth of mesenchymal cells.Ā
Host
Mouse
Immunogen
Bovine TGF-beta2 protein
Isotype
IgG1 Kappa
Positive Control
Salivary gland carcinoma
Reactivity
Human, Monkey, Cow, Dog, Mouse, Rat, Hamster
Recombinant
FALSE
Regulatory
RUO
Swissprot
P01137; P10600; P61812
Uniprot
645227
Gene Id
7040;7042;7043
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
Neut, Functional Assay
Description
Cytokine Neutralization (Order Ab without BSA/Azide); Functional Assay (Order Ab without BSA/Azide); Optimal dilution for a specific application should be determined., Neut ; Functional Assay
Dilution
Neut
Functional Assay
Reviews of Anti-TGF-beta (Transforming Growth Factor beta) Antibody BHA10205275